PMV Pharmaceuticals Inc (PMVP)

NASDAQ

$1.28

PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey.

Website: https://www.pmvpharma.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $4 (+212.50%)

Market Cap

$75M

P/B Ratio

0.87

Beta (5Y)

0.62

Price Chart

Adjust inflation

Log

Valuation

Market Cap$75M

P/B0.87

Profitability

EBITDA-$84M

EPS-$1.47

Growth & Risk

EPS 5Y CAGR+5.51%

FCF 5Y CAGR+14.74%

Beta (5Y)0.62

Sharpe Ratio0.24